Milestone Scientific (MLSS) Proxy filing summary

Executive summary

• Annual Meeting scheduled for July 27, 2026, to be held virtually, with shareholders able to vote and submit questions online.

• Key proposals include director elections, amendments to increase authorized shares and equity plan shares, say-on-pay, and auditor ratification.

• Proxy materials are distributed electronically to reduce costs and environmental impact.

• Forward-looking statements are included, with risks referenced in prior SEC filings.

Voting matters and shareholder proposals

• Shareholders will vote on: (1) election of five directors, (2) amendment to increase authorized common shares from 125M to 135M, (3) amendment to increase shares under the 2020 Equity Incentive Plan from 11.5M to 28.75M, (4) advisory say-on-pay, (5) ratification of Grassi & Co. as auditors, and (6) other business.

• Each proposal has specific voting requirements; only auditor ratification is considered a routine matter for broker voting.

• Board recommends voting FOR all proposals.

Board of directors and corporate governance

• Five nominees for director: Benedetta Casamento (Chair), Neal Goldman (Vice Chair), Eric Hines (CEO), Dr. Didier Demesmin, and Dr. Dawood Sayed.

• Board structure separates Chairman and CEO roles for effective governance.

• Three standing committees: Audit, Compensation, and Nominating & Corporate Governance, each with defined charters and independent members.

• Board independence confirmed for three directors; director candidates evaluated on integrity, experience, and fit.